OrSense NBM-200 selected by Central Blood Bank of Catalonia

OrSense Ltd. announced that its NBM-200 non-invasive hemoglobin measurement device was selected by Banc de Sang I Teixits, the central blood bank of Catalonia, under a two-year contract with three one-year extension options.

“We are very happy with the Banc de Sang's decision to select the NBM-200 again.”prnewswire.com

• 1 source
• prnewswire.comOrSense NBM-200 Non-Invasive Hemoglobin Device Selected by the Central Blood Bank of CataloniaOrSense Ltd.Jul 12, 2019

Summarized from public sources; check the original articles before acting on it.